Pathstone Family Office’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Pathstone Family Office’s Portfolio VAXX Stock Details VAXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$211K	Hold	153,846	–	–	﹤0.01%	1491
2023 Q2	$388K	Buy	+153,846	New	+$326K	0.01%	860

Other funds holding VAXX

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Scoggin Management New York $1.04B AUM 232.32% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Pathstone Family Office's VAXX Position: Q3 2023 in Review

Pathstone Family Office held its Vaxxinity, Inc. Class A Common Stock (VAXX) position steady in Q3 2023 at 153,846 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #1491.

Pathstone Family Office first reported a position in VAXX in Q2 2023 and has held it in 2 quarters since. The position peaked at $388K in Q2 2023. 52 funds tracked by Wall St. Rank hold VAXX as of Q3 2023.

Pathstone Family Office held 153,846 shares of Vaxxinity, Inc. Class A Common Stock worth $211K as of Q3 2023.
Pathstone Family Office left its Vaxxinity, Inc. Class A Common Stock share count unchanged in Q3 2023.
Vaxxinity, Inc. Class A Common Stock made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1491 holding.
Pathstone Family Office first reported a position in Vaxxinity, Inc. Class A Common Stock in Q2 2023 and has held it in 2 quarters since.
Pathstone Family Office's Vaxxinity, Inc. Class A Common Stock position peaked at $388K in Q2 2023.
52 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.